Pages that link to "Q30430578"
Jump to navigation
Jump to search
The following pages link to Synthetic generation of influenza vaccine viruses for rapid response to pandemics (Q30430578):
Displaying 50 items.
- Characterization of uncultivable bat influenza virus using a replicative synthetic virus (Q21089589) (← links)
- Synthetic biology in mammalian cells: next generation research tools and therapeutics (Q26995293) (← links)
- Vaccines for the 21st century (Q27007529) (← links)
- Designing vaccines for the twenty-first century society (Q27025703) (← links)
- Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans. (Q27320929) (← links)
- Delivering vaccines to the people who need them most (Q28082744) (← links)
- Rational Design of High-Number dsDNA Fragments Based on Thermodynamics for the Construction of Full-Length Genes in a Single Reaction (Q28551881) (← links)
- Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial (Q30204573) (← links)
- Use of highly pathogenic avian influenza A(H5N1) gain-of-function studies for molecular-based surveillance and pandemic preparedness (Q30205712) (← links)
- Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study (Q30210097) (← links)
- Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. (Q30352405) (← links)
- Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge. (Q30357409) (← links)
- Bringing influenza vaccines into the 21st century. (Q30357413) (← links)
- Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. (Q30358954) (← links)
- Perspective: Ill prepared for a pandemic. (Q30359975) (← links)
- A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant (Q30360627) (← links)
- Seasonal influenza vaccination and technologies. (Q30360897) (← links)
- Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission (Q30362329) (← links)
- Ethical alternatives to experiments with novel potential pandemic pathogens. (Q30362738) (← links)
- Considerations for the rapid deployment of vaccines against H7N9 influenza. (Q30364635) (← links)
- H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine. (Q30367467) (← links)
- Influenza vaccines: a moving interdisciplinary field. (Q30367695) (← links)
- Emerging influenza viruses and the prospect of a universal influenza virus vaccine. (Q30372274) (← links)
- Haemagglutinin mutations and glycosylation changes shaped the 2012/13 influenza A(H3N2) epidemic, Houston, Texas. (Q30374828) (← links)
- Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice. (Q30375250) (← links)
- ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans. (Q30375901) (← links)
- A paradigm shift in vaccine production for pandemic influenza. (Q30377766) (← links)
- An overview of the regulation of influenza vaccines in the United States (Q30390639) (← links)
- Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus (Q30390811) (← links)
- Vaccines, new opportunities for a new society (Q30390904) (← links)
- Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses (Q33573489) (← links)
- RNA virus reverse genetics and vaccine design. (Q33963398) (← links)
- Simultaneous non-contiguous deletions using large synthetic DNA and site-specific recombinases (Q34044236) (← links)
- Large-scale de novo DNA synthesis: technologies and applications (Q34417984) (← links)
- Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages (Q35606494) (← links)
- Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant (Q35668481) (← links)
- Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells (Q36084675) (← links)
- Multiplex pairwise assembly of array-derived DNA oligonucleotides (Q36701000) (← links)
- Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones (Q37083396) (← links)
- Genotyping and detection of common avian and human origin-influenza viruses using a portable chemiluminescence imaging microarray (Q37366083) (← links)
- mRNA-based therapeutics--developing a new class of drugs (Q38252360) (← links)
- RNA-based viral vectors (Q38266413) (← links)
- Ferritin family proteins and their use in bionanotechnology. (Q38312469) (← links)
- Mapping the evolutionary trajectories of morbilliviruses: what, where and whither (Q38752644) (← links)
- Synthetic virus seeds for improved vaccine safety: Genetic reconstruction of poliovirus seeds for a PER.C6 cell based inactivated poliovirus vaccine (Q38835985) (← links)
- Synthetic DNA Synthesis and Assembly: Putting the Synthetic in Synthetic Biology (Q39066272) (← links)
- Improving influenza virus backbones by including terminal regions of MDCK-adapted strains on hemagglutinin and neuraminidase gene segments (Q39105934) (← links)
- Zika vaccine trials (Q40055024) (← links)
- Digital-to-biological converter for on-demand production of biologics (Q40182050) (← links)
- High-fidelity de novo synthesis of pathways using microchip-synthesized oligonucleotides and general molecular biology equipment. (Q41094270) (← links)